You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Data-Driven Hypersonic Turbulence Modeling Toolset

    SBC: ATA ENGINEERING, INC.            Topic: N22AT016

    Development of hypersonic aircraft and weapon systems has become a critical focus for the Department of Defense to maintain global strike and projection of force capabilities. Despite decades of research, traditional computational fluid dynamics (CFD) methods are either incapable of adequately predicting complex features in hypersonic flows or too expensive to be of practical use for vehicle desig ...

    STTR Phase II 2024 Department of DefenseNavy
  2. STTR Phase II:Scaling the Purification of Mycosporine-like Amino Acids to Replace Chemical Ultraviolet (UV) Filters and Protect Human and Environmental Health.

    SBC: Percev LLC            Topic: CT

    The broader impact of this Small Business Technology Transfer (STTR) Phase II project will be to bring a new class of full spectrum Ultraviolet A and B (UVA and UVB) protective materials to market.Current chemical sunscreen ingredients raise health concerns for consumers.Additionally, some ingredients are banned for causing potential damage to coral reef ecosystems. Consumers increasingly want pro ...

    STTR Phase II 2023 National Science Foundation
  3. STTR Phase II:Ultra-thin Laminar Flywheels for Utility Scale Energy Storage

    SBC: Storx Technologies, Inc.            Topic: PM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase II project is to reduce power infrastructure bottlenecks to the deployment of electric vehicle fast chargers. Typically, it is expensive to install high power electric vehicle fast chargers because of limited power availability or demand charges. A large network of electric vehicle fast chargers would r ...

    STTR Phase II 2023 National Science Foundation
  4. STTR Phase II:Accurate Fetal Health Monitoring During Labor and Delivery

    SBC: Soheil Ghiasi            Topic: MD

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase II project is to advance an innovative method of fetal monitoring, which has the prospect of improving outcomes, reducing cost, and promoting equitable access to quality care during childbirth. The project serves the aligned interest of several key stake holders: patients, payers, providers and policy m ...

    STTR Phase II 2023 National Science Foundation
  5. STTR Phase II:VaxMAP a single dose multivalent vaccine to produce durable and cross-reactive immunity against various coronaviruses

    SBC: Tempo Therapeutics Inc            Topic: BM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase II project will address the unmet need for more effective vaccines that can be rapidly deployed to decrease the lag time between pathogen emergence and vaccine development, minimizing socioeconomic effects such as those seen in the COVID-19 pandemic. This new vaccine technology has the potential to dras ...

    STTR Phase II 2023 National Science Foundation
  6. Mobile Fuel Cell Generator Phase II

    SBC: ROCKETRUCK INC            Topic: C5407f

    The Mobile Fuel Cell Generator (MFCG) addresses needs to increase the reliability of electricity delivery, using equitable, inclusive, sustainable solutions. To address this problem, RockeTruck is developing a portable generator that can be easily transported to deliver clean electric power when grid power is not available. This can include temporary needs, such as utility-mandated “Public Servi ...

    STTR Phase II 2023 Department of Energy
  7. TRISO Fuel Qualification Modeling and Experiment Design

    SBC: Radiant Industries, Incorporated            Topic: C5436b

    As TRISO-coated nuclear fuels are increasingly planned for use in forthcoming commercial reactor designs, qualification strategies for the fuel form are of increasing interest. In the shortterm, it is expected that U.S. based reactor developers will collect irradiation experiment data for their TRISO fuel designs that deviate in any product specifications or extend outside of the operational envel ...

    STTR Phase II 2023 Department of Energy
  8. Solving Sepsis: Early Identification and Prompt Management Using Machine Learning

    SBC: Cohere-Med, Inc.            Topic: 300

    Abstract This fast-track STTR application proposes to enhance, validate, and scale Sepsis Watch, a deep learning sepsis detection and management system built using data from the Emergency Department (ED) Duke University Hospital (DUH). The proposal will extend and enhance Sepsis Watch to EDs, general inpatient wards, and intensive care unit (ICU) settings across multiple health systems in the Unit ...

    STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes

    SBC: VALA SCIENCES, INC.            Topic: NHLBI

    Cardiotoxicity is a leading cause of drug discovery attrition across all of preclinical and clinical drug discovery. While the FDA and the Comprehensive in vitro Proarrhythmia Assay initiative (CiPA) are focused primarily on predicting proarrhythmic effects, drug attrition due to cardiomyopathy, or primary cardiac cytotoxicity, may be even more prevalent, is typically currently only carried out vi ...

    STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  10. Selective targeting of high affinity alpha4 integrins as a safe treatment strategy for IBD

    SBC: Aviara Pharmaceuticals, Inc.            Topic: 300

    Inflammatory bowel disease (IBD) is comprised mainly of Crohn’s Disease (CD) and Ulcerative Colitis (UC), and is characterized by a chronic non-resolving inflammatory response in the intestinal mucosa. Although the exact etiology is unknown, dysbiosis, genetic, environmental, and immunologic factors are all thought to play roles in this multifactorial disease. There are no cures, and in most cas ...

    STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government